Compile Data Set for Download or QSAR
Report error Found 84 of ic50 data for polymerid = 50004085
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113443(CHEMBL3604484)
Affinity DataIC50: 0.300nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178705(CHEMBL3814804)
Affinity DataIC50: 1.5nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50398334(CHEMBL2178578)
Affinity DataIC50: 2.60nMAssay Description:Antagonist activity at recombinant human CCR9B expressed in BAF3 cells assessed as reduction in CCL25-induced chemotaxis preincubated for 10 mins fol...More data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50398334(CHEMBL2178578)
Affinity DataIC50: 2.80nMAssay Description:Antagonist activity at recombinant human CCR9A expressed in BAF3 cells assessed as reduction in CCL25-induced chemotaxis preincubated for 10 mins fol...More data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50398334(CHEMBL2178578)
Affinity DataIC50: 2.80nMAssay Description:Antagonist activity at CCR9 assessed as inhibition of CCL25-induced chemotaxis by cell based assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113442(CHEMBL3604485)
Affinity DataIC50: 3.20nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113441(CHEMBL3604486)
Affinity DataIC50: 3.20nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113352(CHEMBL3604487)
Affinity DataIC50: 3.80nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113354(CHEMBL3604489)
Affinity DataIC50: 4nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50398334(CHEMBL2178578)
Affinity DataIC50: 5nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50398334(CHEMBL2178578)
Affinity DataIC50: 6nMAssay Description:Binding affinity to CCR9More data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113427(CHEMBL3604496)
Affinity DataIC50: 6nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178714(CHEMBL3814136)
Affinity DataIC50: 8nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113440(CHEMBL3604483)
Affinity DataIC50: 8.70nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113358(CHEMBL3604493)
Affinity DataIC50: 9nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50398334(CHEMBL2178578)
Affinity DataIC50: 10nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113360(CHEMBL3604495)
Affinity DataIC50: 11nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113353(CHEMBL3604488)
Affinity DataIC50: 11nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50398334(CHEMBL2178578)
Affinity DataIC50: 11nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) by buffer chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113357(CHEMBL3604492)
Affinity DataIC50: 14nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178704(CHEMBL3814736)
Affinity DataIC50: 20nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113352(CHEMBL3604487)
Affinity DataIC50: 23nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) by buffer chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113441(CHEMBL3604486)
Affinity DataIC50: 23nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) by buffer chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113428(CHEMBL3604497)
Affinity DataIC50: 25nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113359(CHEMBL3604494)
Affinity DataIC50: 26nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113355(CHEMBL3604490)
Affinity DataIC50: 27nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178716(CHEMBL3814511)
Affinity DataIC50: 29nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113438(CHEMBL3604476)
Affinity DataIC50: 29nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113354(CHEMBL3604489)
Affinity DataIC50: 30nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) by buffer chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113430(CHEMBL3604499)
Affinity DataIC50: 34nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) by buffer chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113430(CHEMBL3604499)
Affinity DataIC50: 34nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178707(CHEMBL3814811)
Affinity DataIC50: 35nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178712(CHEMBL3813888)
Affinity DataIC50: 36nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113444(CHEMBL3604482)
Affinity DataIC50: 52nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113427(CHEMBL3604496)
Affinity DataIC50: 60nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) by buffer chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178709(CHEMBL3814683)
Affinity DataIC50: 70nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178713(CHEMBL3815051)
Affinity DataIC50: 75nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178711(CHEMBL3814176)
Affinity DataIC50: 85nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113447(CHEMBL3604478)
Affinity DataIC50: 89nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178717(CHEMBL3815007)
Affinity DataIC50: 93nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113448(CHEMBL3604477)
Affinity DataIC50: 95nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113358(CHEMBL3604493)
Affinity DataIC50: 105nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) by buffer chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178942(CHEMBL3814546)
Affinity DataIC50: 111nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178708(CHEMBL3814251)
Affinity DataIC50: 113nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113430(CHEMBL3604499)
Affinity DataIC50: 170nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) by serum chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113359(CHEMBL3604494)
Affinity DataIC50: 190nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) by buffer chemotaxis assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178943(CHEMBL3814577)
Affinity DataIC50: 207nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50113356(CHEMBL3604491)
Affinity DataIC50: 214nMAssay Description:Antagonist activity at CCR9 receptor (unknown origin) assessed as inhibition of TECK-induced calcium mobilization incubated for 10 mins prior to TECK...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178707(CHEMBL3814811)
Affinity DataIC50: 218nMAssay Description:Inhibition of CCR9-mediated chemotaxis in human MOLT4 cells preincubated for 10 mins followed by TECK addition in presence of 0.1% BSA measured after...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetC-C chemokine receptor type 9(Human)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50178944(CHEMBL3814185)
Affinity DataIC50: 232nMAssay Description:Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Displayed 1 to 50 (of 84 total ) | Next | Last >>
Jump to: